A BBC investigation revealed that fenbendazole and ivermectin, drugs not approved for cancer treatment, are being marketed as cancer therapies. A stairlift salesman in Wales offered these medications, claiming they could shrink tumors, despite a lack of clinical evidence supporting their efficacy. Amazon has since removed these products from its platform after being contacted by the BBC.
Health organizations, including Macmillan Cancer Support, expressed alarm over the potential risks to vulnerable patients who might forego conventional treatments in favor of these unproven drugs. Medical professionals warn that such misinformation could lead to harmful consequences for patients seeking effective cancer care.